Allison Meisner

Allison Meisner, PhD, serves as Assistant Professor in the Department of Global Health at the University of Washington and holds multiple appointments at Fred Hutchinson Cancer Center (Fred Hutch), including Assistant Professor in the Cancer Prevention Program (Public Health Sciences Division), Affiliate Investigator in the Clinical Research Division, and Member of the Translational Data Science Integrated Research Center (TDS IRC).

Her educational background comprises a PhD in Biostatistics from the University of Washington (2017), MA in Biostatistics from Boston University (2011), BS in Biomedical Engineering from the University of Connecticut (2008), and postdoctoral training at Johns Hopkins University Department of Biostatistics (2020).

Dr. Meisner specializes in risk prediction methodologies with expertise in polygenic risk scores, biomarker combinations, causal inference frameworks, and SMART trial designs for treatment selection. Her research bridges biostatistical innovation with practical applications in infectious disease prevention and cancer risk assessment. Prior work includes HIV prevention trials with the HIV Prevention Trials Network (HPTN), implementation research in sub-Saharan Africa, and diagnostic test evaluations for tuberculosis and COVID-19.

Current research initiatives focus on PrEP (pre-exposure prophylaxis) implementation, including The Effect of Pharmacy-Delivered PrEP Services on Reach and Access in Kenya, Evaluation of Stepped PrEP Adherence Support for Young South African Women Using a SMART Design, and PrEP-aring Family Planning Clinics to Streamline HIV Prevention Services for Young Women in Kenya.

As a TDS IRC member, she contributes to interdisciplinary data science applications in biomedical research, particularly in translational statistics for public health interventions.